Fenbendazole 444 Mg

Last Updated on 10/30/2026 ✔ Medically Reviewed by Dr. Arjun Srivastav

Fenbendazole 444 Mg refers to a veterinary anthelmintic preparation containing 444 mg of the active ingredient fenbendazole. Fenbendazole belongs to the benzimidazole class of antiparasitic agents.

It has an established role in animal health for controlling gastrointestinal parasites in species such as dogs, cats, cattle, sheep, horses and rabbits. This page presents verified product information and regulatory context for Fenbendazole 444 Mg within its approved veterinary framework.

It also distinguishes registered animal use from unapproved human use claims that appear online. This helps readers separate established veterinary application from unsupported self treatment practises.

Fenbendazole 444 Mg Product Information

The following details relate to the Fenbendazole 444 Mg tablet product associated with the Wormentel brand:

No Australian registration details for this specific product could be verified. It should not be assumed to be APVMA registered or ARTG listed without confirming a registration number through the official APVMA or TGA databases. Buyers should verify all product details against the original label and packaging.

What Is Fenbendazole 444 Mg?

Fenbendazole is the active ingredient in Fenbendazole 444 Mg and in a group of veterinary anthelmintic medicines classified as benzimidazoles. As a broad spectrum anthelmintic, it is used in animal health to address certain parasite infections.

Pharmacologically, benzimidazoles act on structures within the parasite cell. Fenbendazole is recognised for its selective affinity for parasite tubulin over mammalian tubulin, which underpins its veterinary application.

Veterinary medicines and human medicines are regulated under separate frameworks because their safety, quality and efficacy data are evaluated against different standards. A product registered for animal use has been assessed for the target animal species and conditions stated on its label, not for human patients.

For this reason the registered indications, dosage and safety information on a veterinary product label apply only within that veterinary context. They cannot be transferred to human use. For a broader explanation of the active ingredient, its classification and established veterinary role, see our guide to what fenbendazole is.

What Does Fenbendazole 444 Mg Mean?.

The 444 in Fenbendazole 444 Mg indicates the strength of the active ingredient. Each tablet contains 444 mg of fenbendazole.

This figure refers to the active pharmaceutical ingredient rather than the total weight of the tablet. The tablet also includes excipients and other formulation components.

Strength alone does not establish suitability or determine dosing. The appropriate use of any fenbendazole product depends on the animal species, body weight, formulation and the specific registered label instructions.

A 444 mg strength is simply a concentration statement and not a treatment direction. Buyers should always check the original packaging, label and product information to confirm the active ingredient, strength, dosage form, manufacturer details and any applicable registration information before use.

Uses of Fenbendazole 444 Mg

Fenbendazole 444 Mg has an established role in veterinary parasitic control. It appears in registered veterinary products used across several animal species.

Relevant registered labels cover animals such as dogs, cats, cattle, sheep, horses and rabbits. The approved indications are specified on each product label.

The approved indications can differ between products because each veterinary medicine is registered for particular species, parasite targets and administration routes. This is based on the evidence supporting that specific product.

For example, one product may be registered for use in cattle and horses for particular roundworms and lungworms. Another may be registered for dogs and cats for different gastrointestinal parasites.

These differences mean veterinary indications cannot be generalised across species or assumed from the active ingredient alone. The registered label, not the ingredient name, defines what a specific product may be used for, in which animal, and under what conditions.

How Does Fenbendazole 444 Mg Work?

Fenbendazole is classified as a benzimidazole anthelmintic. Its recognised mode of action involves binding to beta tubulin, a protein that forms part of the microtubules in parasite cells.

By binding to parasite beta tubulin, fenbendazole disrupts the formation of microtubules. These are structures involved in nutrient transport, cell division and other essential cellular processes within the parasite.

This disruption interferes with the parasite ability to absorb nutrients, particularly glucose. It also disrupts the parasite energy metabolism. As the parasite depletes its energy reserves it is unable to maintain vital functions and is eventually expelled.

The Therapeutic Goods Administration October 2025 scheduling decision describes fenbendazole as working by binding to tubulin, a protein that is part of the microtubules in the cells of parasites. This leads to parasites being unable to absorb nutrients, resulting in their eventual death.

Established veterinary pharmacology similarly identifies beta tubulin binding and microtubule disruption as the core mechanism by which benzimidazole anthelmintics act on parasites.

Which Parasites Can Fenbendazole 444 Mg Target in Animals?

Within its registered veterinary context, Fenbendazole 444 Mg is associated with activity against several gastrointestinal parasites in animals. Parasitic infections can involve different organisms and affect different parts of the body. Our guide explains what a parasite infection is and the main types that can affect humans and animals.

These include:

• Roundworms
• Hookworms
• Whipworms
• Certain tapeworm species, including the tapeworm genus Taenia

The TGA scheduling decision notes that fenbendazole is not effective against Dipylidium caninum, a common dog tapeworm. This illustrates that parasite response is not uniform.

Species specific differences and limitations apply, and the parasites targeted depend on the product, the animal and the registered label. Not all parasites respond to fenbendazole.

The registered indications for one product or species should not be extended to others. The product label remains the authoritative source for which parasites a particular fenbendazole product is registered to target.

Veterinary Administration and Dosage Considerations for Fenbendazole 444 Mg

Veterinary administration and dosage of Fenbendazole 444 Mg depend on several factors that must be considered together:

• The animal species, because a product registered for one species may not be appropriate for another
• Body weight, because veterinary dosing is typically weight based
• The diagnosis and the specific parasite being addressed, which guide whether fenbendazole is the suitable choice
• The formulation, whether oral paste, granules, liquid suspension or tablet, which determines the administration method
• The instructions on the product label, which set the administration schedule

Signs of a parasitic infection can vary depending on the organism, affected body system and animal species. This overview of parasite infection symptoms provides additional background on how symptoms can differ. Veterinary supervision is important. A veterinarian can confirm the diagnosis, select the appropriate product and calculate the correct amount for the individual animal.

A Fenbendazole 444 Mg tablet should not be treated as a universal dose. The strength indicates the active ingredient per tablet, while the actual amount to give depends on the species, weight, formulation and label directions for the specific product.

Possible Side Effects of Fenbendazole 444 Mg

Product label safety information is the primary reference for understanding possible side effects associated with a Fenbendazole 444 Mg veterinary product. The label provides details relevant to the registered use, including any warnings, contraindications and precautions that apply to the target animal species.

Safety Precautions for Fenbendazole 444 Mg

Safety considerations can be species specific. A precaution relevant to one animal may not apply to another, and some products carry particular warnings for certain species.

Where evidence exists, product labels may also include pregnancy and reproductive considerations. These should be reviewed before use in breeding or pregnant animals.

Benzimidazole anthelmintics are generally recognised as having a wide margin of safety in their registered veterinary context. This does not remove the need to follow label directions.

Adverse reactions, if they occur, should be reported to the appropriate veterinary or regulatory authority, and a veterinarian should be consulted. Professional veterinary advice is important before using any fenbendazole product, to confirm suitability for the animal, review the diagnosis and ensure the product is used in line with its registered label.

Is Fenbendazole 444 Mg Approved for Human Use in Australia?

Fenbendazole 444 Mg is not approved for human use in Australia. In its October 2025 scheduling decision, the Therapeutic Goods Administration created a new entry for fenbendazole as a Schedule 4 prescription only medicine, with an exception when included in Schedule 5.

The Schedule 4 classification means that preparations of fenbendazole for human use require a prescription. The Schedule 5 exception applies to fenbendazole for the treatment of animals, which retains its established veterinary pathway.

The TGA decision states that fenbendazole has not been evaluated for safety, quality and efficacy by the TGA. Its pharmacokinetics and safety in humans have yet to be established in clinical trials or medical literature.

The distinction between veterinary safety information and human safety evidence is important. Our discussion of potential side effects of fenbendazole in humans explains the limitations of the available human safety information.

The decision also confirms that fenbendazole is not approved for human use in Australia or by overseas regulatory bodies including the United States Food and Drug Administration and the European Medicines Agency.

Regarding the Australian Register of Therapeutic Goods, the decision notes there are currently no therapeutic goods registered in Australia that contain fenbendazole as an active ingredient. There have been no applications for products containing fenbendazole to be considered for inclusion on the ARTG.

For these reasons veterinary formulations of fenbendazole should not be used for human self treatment. They have not been assessed for human safety, quality or efficacy, and their use in humans is not supported by registered therapeutic goods in Australia.

What Does Human Research Say About Fenbendazole 444 Mg?

Human research on Fenbendazole 444 Mg remains preliminary and limited. Most available information comes from laboratory research, including in vitro studies, and from animal research, rather than from completed human clinical trials.

There is no established human clinical efficacy for fenbendazole. No established human therapeutic dosage has been defined through clinical study.

The TGA notes that in the absence of completed clinical trials testing fenbendazole in humans, insights are drawn from in vitro and in vivo animal studies. This distinction matters because preliminary research and approved treatment are not the same.

Early stage findings do not establish that fenbendazole is safe or effective for human use. They do not constitute an approved treatment.

Storage and Handling Information for Fenbendazole 444 Mg

Fenbendazole 444 Mg tablets should be kept in their original packaging until use. The manufacturer storage instructions printed on the label should be followed, including any guidance on temperature and conditions.

Safe handling is important, and the product should be stored in line with label directions. Medicines should be kept away from children and away from animals for which the product is not intended, where relevant.

Medical and Veterinary Disclaimer

This page is informational only. It does not constitute medical or veterinary advice, diagnosis or treatment. The evidence described is limited and preliminary. Readers should follow applicable professional and regulatory guidance and consult a qualified veterinarian or doctor before using any product.

Fenbendazole 444 Mg In Brief:

Fenbendazole 444 Mg is an extremely effective medication for getting relief from infections caused by parasites. However, the drug must be taken according to weight, intensity of the infection, and age. Hence, always go according to the doctor’s guide. Once you have the prescription, upload it to the australiarxmeds website and get the drug at your doorstep.